| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Lyophilized powder for conventional release suspension for injection (dose form) |
Is a |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Powder for prolonged-release suspension for injection (dose form) |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Lyophilized powder for prolonged-release suspension for injection (dose form) |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| frystorkat pulver till injicerbar liposomsuspension |
Is a |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| leuprorelinacetat 7,5 mg, pulver till injektionsvätska, suspension, flaska |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| leuprorelinacetat 30 mg, pulver till injektionsvätska, suspension, flaska |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| leuprorelinacetat 11,25 mg, pulver till injektionsvätska, suspension, flaska |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| leuprorelinacetat 22,5 mg, pulver till injektionsvätska, suspension, flaska |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| cilastatin (som cilastatinnatrium) 500 milligram/injektionsflaska och imipenem (som imipenemmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska, suspension |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| olanzapin 300 mg, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| olanzapin 210 mg, pulver till injektionsvätska |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| olanzapin 405 mg, pulver till injektionsvätska, suspension |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| leuprorelinacetat 45 mg, pulver till injektionsvätska, suspension, flaska |
Has manufactured dose form |
False |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Paclitaxel 100 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Risperidone 12.5 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Risperidone 50 mg powder for suspension for injection vial |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|
| Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for suspension for injection |
Inferred relationship |
Some |
|